KR20070048741A - 디아릴사이클로알킬 유도체의 제조방법 - Google Patents

디아릴사이클로알킬 유도체의 제조방법 Download PDF

Info

Publication number
KR20070048741A
KR20070048741A KR1020077004449A KR20077004449A KR20070048741A KR 20070048741 A KR20070048741 A KR 20070048741A KR 1020077004449 A KR1020077004449 A KR 1020077004449A KR 20077004449 A KR20077004449 A KR 20077004449A KR 20070048741 A KR20070048741 A KR 20070048741A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
cis
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077004449A
Other languages
English (en)
Korean (ko)
Inventor
크리스토프 살라냐
프랑크 초허
안드레아스 부르가르트
베른트 윤커
롤프 회를라인
토마스 슈튀데만
클라우스-위르겐 마이어
요헨 하흐텔
볼프강 홀라
크리스토프 탑페르츠호펜
베른트 쿨리춰
스테판 무티
Original Assignee
사노피-아벤티스 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 도이칠란트 게엠베하 filed Critical 사노피-아벤티스 도이칠란트 게엠베하
Publication of KR20070048741A publication Critical patent/KR20070048741A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020077004449A 2004-08-23 2005-08-23 디아릴사이클로알킬 유도체의 제조방법 Ceased KR20070048741A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040736A DE102004040736B4 (de) 2004-08-23 2004-08-23 Verfahren zur Herstellung von Diarylcycloalkylderivaten
DE102004040736.3 2004-08-23

Publications (1)

Publication Number Publication Date
KR20070048741A true KR20070048741A (ko) 2007-05-09

Family

ID=35745474

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077004449A Ceased KR20070048741A (ko) 2004-08-23 2005-08-23 디아릴사이클로알킬 유도체의 제조방법

Country Status (27)

Country Link
US (2) US7803950B2 (enExample)
EP (1) EP1786913B1 (enExample)
JP (1) JP4991543B2 (enExample)
KR (1) KR20070048741A (enExample)
CN (1) CN101014714B (enExample)
AR (1) AR053760A1 (enExample)
AT (1) ATE520785T1 (enExample)
AU (1) AU2005276642B2 (enExample)
BR (1) BRPI0514000A (enExample)
CA (1) CA2578342A1 (enExample)
CY (1) CY1112080T1 (enExample)
DE (1) DE102004040736B4 (enExample)
DK (1) DK1786913T3 (enExample)
ES (1) ES2371762T3 (enExample)
IL (1) IL181339A0 (enExample)
MA (1) MA28796B1 (enExample)
MX (1) MX2007001872A (enExample)
NO (1) NO20071316L (enExample)
NZ (1) NZ553602A (enExample)
PL (1) PL1786913T3 (enExample)
PT (1) PT1786913E (enExample)
RU (1) RU2414459C2 (enExample)
SI (1) SI1786913T1 (enExample)
TW (1) TW200621734A (enExample)
UY (1) UY29082A1 (enExample)
WO (1) WO2006021420A2 (enExample)
ZA (1) ZA200700635B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101381302B (zh) * 2007-09-07 2013-04-03 上海睿智化学研究有限公司 2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
ES2601852T3 (es) * 2008-01-25 2017-02-16 Xenoport, Inc. Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728899A (en) * 1995-03-27 1998-03-17 Hoechst Marion Roussel Inc. Preparation of cis-4-O-protected-2-cyclopentenol derivatives
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
AU2002333456B2 (en) * 2001-08-31 2008-07-17 Sanofi-Aventis Deutschland Gmbh Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as PPAR activators
JP2005529077A (ja) * 2002-02-25 2005-09-29 イーライ・リリー・アンド・カンパニー ペルオキシソーム増殖因子活性化受容体調節物質
US7094795B2 (en) * 2003-02-27 2006-08-22 Sanofi-Aventis Deutschland Gmbh Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308350B4 (de) * 2003-02-27 2006-06-01 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
EP1689874A1 (fr) * 2003-10-22 2006-08-16 Rhodia Chimie Procede de fabrication de compose comprenant un groupement hydroxyle libre et un groupement hydroxyle protege par une fonction ester par reaction enzymatique
DE102004038403B4 (de) * 2004-08-07 2006-08-31 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten

Also Published As

Publication number Publication date
ATE520785T1 (de) 2011-09-15
BRPI0514000A (pt) 2008-05-20
WO2006021420B1 (de) 2007-02-08
DE102004040736B4 (de) 2007-01-11
WO2006021420A3 (de) 2006-12-21
PL1786913T3 (pl) 2012-01-31
RU2007110644A (ru) 2008-09-27
NO20071316L (no) 2007-05-22
PT1786913E (pt) 2011-10-31
WO2006021420A2 (de) 2006-03-02
NZ553602A (en) 2010-04-30
JP4991543B2 (ja) 2012-08-01
EP1786913A2 (de) 2007-05-23
EP1786913B1 (de) 2011-08-17
MX2007001872A (es) 2007-04-24
UY29082A1 (es) 2006-03-31
IL181339A0 (en) 2007-07-04
ES2371762T3 (es) 2012-01-09
US20080051583A1 (en) 2008-02-28
TW200621734A (en) 2006-07-01
CA2578342A1 (en) 2006-03-02
JP2008510761A (ja) 2008-04-10
DK1786913T3 (da) 2011-11-28
AR053760A1 (es) 2007-05-23
CN101014714A (zh) 2007-08-08
AU2005276642B2 (en) 2011-12-22
SI1786913T1 (sl) 2011-12-30
CN101014714B (zh) 2012-05-23
MA28796B1 (fr) 2007-08-01
US7803950B2 (en) 2010-09-28
DE102004040736A1 (de) 2006-03-02
CY1112080T1 (el) 2015-11-04
RU2414459C2 (ru) 2011-03-20
US20070197614A1 (en) 2007-08-23
ZA200700635B (en) 2010-01-27
AU2005276642A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
EP3483161B1 (en) Intermediates used to make entecavir
US20070197788A1 (en) Method for the preparation of enantiomer forms of cis-configured 3-hydroxycyclohexane carboxylic acid derivatives using hydrolases
US6515134B1 (en) Substituted acetylpridine derivatives and process for the preparation of intermediates for optically active beta-3 agonist by the use of the same
EP2218722B1 (en) Process for producing benzoxazine derivative and production intermediate thereof
KR20040027404A (ko) 글리시딜프탈이미드의 제조방법
US7803950B2 (en) Method for the production of diarylcycloalkyl derivatives
Futamura et al. Efficient route to (S)-azetidine-2-carboxylic acid
KR101399551B1 (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
EP1063232A2 (en) Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
Chen et al. Substrate stereocontrol in bromine-induced intermolecular cyclization: asymmetric synthesis of pitavastatin calcium
HK1105999A (en) Method for the production of diarylcycloalkyl derivatives
JP3704731B2 (ja) 光学活性３−ヒドロキシヘキサン酸類の製造方法
WO2007126258A1 (en) The method of making optically active 2-halo-2-(n-substituted phenyl)acetic acid esters and 2-halo-2-(n-substituted phenyl)acetic acids by enzymatic method
JPH04295469A (ja) キノキサリニルオキシフェノキシプロピオン酸の光学活性エステルの製造方法
JP2974181B2 (ja) シクロブタノールの新規な製造法
CA2216245C (en) Preparation of cis-4-o-protected-2-cyclopentenol derivatives
JP2000256236A (ja) 光学活性アルコール化合物の製造方法
JPH11313695A (ja) 光学活性３，３，３−トリフルオロ−２−ヒドロキシ−２−メチルプロピオン酸の製造方法
JPH03232873A (ja) 光学活性シス―４―ヒドロキシ―３―置換テトラヒドロフラン誘導体およびその製造方法
JP2002080463A (ja) ホスゲンを用いた２，４−オキサゾリジンジオン類の製造方法
JP2007204420A (ja) ビカルタミドおよびそのアナログの製造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070223

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20100719

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120229

Patent event code: PE09021S01D

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120928

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130329

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20120928

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20120229

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I